Form 4: Vita Coco CEO Sells Shares Under 10b5-1 Plan

Vita Coco Company CEO Martin Roper sold 20,000 shares of common stock for approximately $40 per share through a pre-arranged Rule 10b5-1 trading plan.

Summary

• Martin Roper, Chief Executive Officer and Director of Vita Coco Company, Inc. (COCO), reported transactions on September 12, 2025.
• Roper sold a total of 20,000 shares of common stock.
• The sales were executed under a pre-arranged Rule 10b5-1 trading plan.
• 15,000 shares were sold indirectly through three separate family trusts (Christopher G. Roper Exempt Family Trust, Peter S. Roper Exempt Family Trust, Thomas L. Roper Exempt Family Trust).
• 5,000 shares were sold directly.
• The weighted average sale prices ranged from $40.005 to $40.019 per share.
• Following these transactions, Roper directly holds 352,062 shares and indirectly holds 61,200 shares through his spouse, and 286,131 shares through each of the three family trusts.
• Roper also holds 1,099,460 non-qualified stock options with exercise prices ranging from $10.178 to $32.78, with various vesting schedules and expiration dates up to March 3, 2035.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, the execution under a Rule 10b5-1 plan mitigates concerns about opportunistic selling. The CEO retains substantial equity and options, indicating continued vested interest in the company's performance.

Positives

• The sales were conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than a reaction to immediate company news.
• Roper retains significant direct and indirect ownership of common stock and substantial stock options, indicating continued alignment with shareholder interests.
• The exercise prices of the stock options are significantly lower than the current sale price, suggesting substantial unrealized gains.

Negatives

• Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces the insider's direct equity stake.

Future Outlook

NA

Industry Context

This Form 4 filing details an insider transaction and does not provide information relevant to broader industry trends or competitive analysis for the beverage sector.

Related Party Transactions

• Martin Roper's indirect sales of 15,000 shares were conducted through three separate family trusts: Christopher G. Roper Exempt Family Trust, Peter S. Roper Exempt Family Trust, and Thomas L. Roper Exempt Family Trust.

Stakeholder Impact

• Shareholders may observe a slight reduction in the CEO's direct and indirect equity holdings, though the sales were pre-planned and a significant stake is retained.

Key Dates

Recommendation

The insider sales were conducted under a Rule 10b5-1 plan, which suggests a pre-scheduled liquidity event rather than a reaction to new company developments. The CEO retains a substantial number of shares and options, indicating continued alignment with shareholder interests. This filing alone does not provide sufficient new information to warrant a change in investment recommendation, thus a 'hold' position is maintained, pending further fundamental analysis.

Keywords

Vita Coco, COCO, Martin Roper, Insider Trading, Form 4, SEC Filing, Stock Sale, 10b5-1 Plan, CEO, Director, Stock Options, Beneficial Ownership